Revisiting paulozzi etal.'s "prescription drug monitoring programs and death rates from drug overdose"

Pain Medicine

Volumn 12, Issue 6, 2011, Pages 982-985

  Green, Traci C ^a,b   Zaller, Nickolas ^b,c   Rich, Josiah ^b,c   Bowman, Sarah ^a   Friedmann, Peter ^a,b  

^a RHODE ISLAND HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c MIRIAM HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRESCRIPTION DRUG; NARCOTIC ANALGESIC AGENT;

DATA ANALYSIS; DRUG ABUSE; DRUG MISUSE; DRUG OVERDOSE; DRUG SURVEILLANCE PROGRAM; EVALUATION; HEALTH CARE PERSONNEL; HUMAN; LAW; LAW ENFORCEMENT; LETTER; MORTALITY; DRUG MONITORING; INTOXICATION; METHODOLOGY; NOTE;

ANALGESICS, OPIOID; DRUG MONITORING; HUMANS; OVERDOSE; PRESCRIPTION DRUGS;

EID: 79959211161     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2011.01136.x     Document Type: Letter

References (16)

1. Katz N, Houle B, Fernandez KC, etal. Update on prescription monitoring in clinical practice: A survey study of prescription monitoring program administrators. Pain Med 2008;9(5):587-94.
2. Bohnert AS, Nandi A, Tracy M, etal. Policing and risk of overdose mortality in urban neighborhoods. Drug Alcohol Depend 2011;113(1):62-8.
3. Cooper H, Moore L, Gruskin S, Krieger N. The impact of a police drug crackdown on drug injectors' ability to practice harm reduction: A qualitative study. Soc Sci Med 2005;61(3):673-84.
4. Brugal MT, Barrio G, Fuente LDL, etal. Factors associated with non-fatal heroin overdose: Assessing the effect of frequency and route of heroin administration. Addiction 2002;97(3):319-27.
5. Darke S, Hall W. Heroin overdose: Research and evidence-based intervention. J Urban Health 2003;80(2):189-200.
6. Caplehorn JR, Dalton MS, Haldar F, Petrenas AM, Nisbet JG. Methadone maintenance and addicts' risk of fatal heroin overdose. Subst Use Misuse 1996;31(2):177-96.
7. Davoli M, Bargagli AM, Perucci CA, etal. Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study. Addiction 2007;102(12):1954-9.
8. Baehren DF, Marco CA, Droz DE, etal. A statewide prescription monitoring program affects emergency department prescribing behaviors. Ann Emerg Med 2010;56(1):19-23. e11-13.
9. Tufts Health Care Institute. Prescription monitoring program update. Program on Opioid Risk Management. Boston, MA; 2009.
10. Katz N, Panas L, Kim M, etal. Usefulness of prescription monitoring programs for surveillance-Analysis of Schedule II opioid prescription data in Massachusetts, 1996-2006. Pharmacoepidemiol Drug Saf 2010;19(2):115-23.
11. Dasgupta N, Sanford C, Albert S, Wells Brason F. Opioid drug overdoses: A prescription for harm and potential for prevention. Am J Lifestyle Med 2010;4(1):32-7.
12. Doe-Simkins M, Walley AY, Epstein A, Moyer P. Saved by the nose: Bystander-administered intranasal naloxone hydrochloride for opioid overdose. Am J Public Health 2009;99(5):788-91.
13. Rich JD, Green TC, McKenzie MS. Opioids and deaths. N Engl J Med 2011;364(7):686.
14. Maxwell S, Bigg D, Stanczykiewicz K, Carlberg-Racich S. Prescribing naloxone to actively injecting heroin users: A program to reduce heroin overdose deaths. J Addict Dis 2006;25(3):89-96.
15. Green TC, Heimer R, Grau LE. Distinguishing signs of opioid overdose and indication for naloxone: An evaluation of six overdose training and naloxone distribution programs in the United States. Addiction 2008;103(6):979-89.
16. Darke S, Mattick RP, Degenhardt L. The ratio of non-fatal to fatal heroin overdose. Addiction 2003;98(8):1169-71.